We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
-2.43%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$161B
AUM Growth
+$2.64B
Cap. Flow
+$8.05B
Cap. Flow %
5.01%
Top 10 Hldgs %
23.87%
Holding
4,832
New
336
Increased
1,838
Reduced
1,886
Closed
249

Top Buys

Rank Stock Value
1
CRH icon
CRH
CRH
+$978M
2
MSFT icon
Microsoft
MSFT
+$812M
3
BAC icon
Bank of America
BAC
+$602M
4
AAPL icon
Apple
AAPL
+$518M
5
NVDA icon
NVIDIA
NVDA
+$412M

Sector Composition

Rank Sector Weight
1 Technology 27.45%
2 Financials 11.83%
3 Healthcare 11.27%
4 Consumer Discretionary 10.12%
5 Communication Services 7.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WHWK
4076
Whitehawk Therapeutics
WHWK
$190M
$13.7K ﹤0.01%
2,827
-401
-12% -$2.33K
EEX
4077
DELISTED
Emerald Holding
EEX
$13.5K ﹤0.01%
2,990
-139
-4% -$589
BCAB icon
4078
BioAtla
BCAB
$5.46M
$13.5K ﹤0.01%
159
-18
-10% -$2.29K
NUTX
4079
Nutex Health
NUTX
$1.01B
$13.5K ﹤0.01%
444
+14
+3% +$675
SID icon
4080
Companhia Siderúrgica Nacional
SID
$1.31B
$13.5K ﹤0.01%
5,640
TCI icon
4081
Transcontinental Realty Investors
TCI
$352M
$13.4K ﹤0.01%
439
+53
+14% +$1.79K
MVLA
4082
DELISTED
Movella Holdings Inc. Common Stock
MVLA
$13.4K ﹤0.01%
24,962
+15,112
+153% +$19.3K
BKKT icon
4083
Bakkt Inc
BKKT
$321M
$13.4K ﹤0.01%
457
-101
-18% -$3.58K
LVOX
4084
DELISTED
LiveVox Holding, Inc. Class A Common Stock
LVOX
$13.3K ﹤0.01%
3,972
-1,205
-23% -$3.71K
FOA icon
4085
Finance of America Companies
FOA
$203M
$13.2K ﹤0.01%
1,031
-41
-4% -$679
TVRD
4086
Tvardi Therapeutics
TVRD
$19.7M
$13.2K ﹤0.01%
217
-43
-17% -$4.03K
CPSS icon
4087
Consumer Portfolio Services
CPSS
$202M
$13.1K ﹤0.01%
1,441
-462
-24% -$4.8K
VHT icon
4088
Vanguard Health Care ETF
VHT
$18.1B
$12.9K ﹤0.01%
55
VCR icon
4089
Vanguard Consumer Discretionary ETF
VCR
$6.15B
$12.9K ﹤0.01%
48
BAER icon
4090
Bridger Aerospace
BAER
$112M
$12.9K ﹤0.01%
1,524
-1,322
-46% -$8.95K
WKHS icon
4091
Workhorse Group
WKHS
$33.2M
$12.7K ﹤0.01%
10
-1
-9% -$2.57K
BIOR
4092
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$12.6K ﹤0.01%
580
FGBI icon
4093
First Guaranty Bancshares
FGBI
$159M
$12.6K ﹤0.01%
1,142
+927
+431% +$10.9K
XGN icon
4094
Exagen
XGN
$109M
$12.5K ﹤0.01%
5,145
BCEL
4095
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$12.4K ﹤0.01%
47,487
VWE
4096
DELISTED
Vintage Wine Estates, Inc. Common Stock
VWE
$12.3K ﹤0.01%
21,645
TGAN
4097
DELISTED
Transphorm, Inc. Common Stock
TGAN
$12.2K ﹤0.01%
5,513
+96
+2% +$268
ELEV
4098
DELISTED
Elevation Oncology
ELEV
$12.2K ﹤0.01%
+18,350
New +$18.6K
PLSE icon
4099
Pulse Biosciences
PLSE
$2.43B
$12.1K ﹤0.01%
2,991
-248
-8% -$1.54K
HWBK icon
4100
Hawthorn Bancshares
HWBK
$269M
$12K ﹤0.01%
+740
New +$12.6K

Similar funds

Barclays's Q3 2023 Portfolio in Review

As of Q3 2023, Barclays held 4,832 positions worth $161B, up 1.7% from $158B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Barclays deployed $8.05B of net new capital in Q3 2023, opening 336 new positions and adding to 1,838 existing holdings. Its largest new stake was CRH: 17,203,754 shares worth $942M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $1.32B trimmed.

  • Barclays's largest Q3 2023 buy was CRH: 17,203,754 shares worth $942M.
  • Barclays added most to Microsoft in Q3 2023, an estimated $812M increase.
  • Barclays's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $1.32B.
  • Barclays fully exited Aerojet Rocketdyne Holdings in Q3 2023, selling an estimated $154M.
  • Barclays's ten largest holdings make up 24% of its $161B portfolio in Q3 2023.
  • Barclays opened 336 new positions and closed 249 in Q3 2023.
  • Barclays's portfolio value rose 1.7% quarter-over-quarter to $161B.

Based on Barclays's 13F filing for Q3 2023, filed 7 Nov 2023.